NR3C2 and cardiovascular disorder: The mineralocorticoid receptor (MR) is an important contributor to chronic kidney disease (CKD) and cardiovascular disease (CVD), mainly through stimulating inflammation, oxidative stress, and tissue fibrosis [4].